Susquehanna International Group’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-29,200
Closed -$836K 10480
2018
Q4
$836K Hold
29,200
﹤0.01% 5035
2018
Q3
$814K Hold
29,200
﹤0.01% 5627
2018
Q2
$815K Sell
29,200
-100
-0.3% -$2.68K ﹤0.01% 5784
2018
Q1
$728K Sell
29,300
-18,700
-39% -$455K ﹤0.01% 5871
2017
Q4
$1.16M Sell
48,000
-24,200
-34% -$638K ﹤0.01% 4932
2017
Q3
$1.99M Buy
72,200
+44,900
+164% +$1.2M ﹤0.01% 3928
2017
Q2
$684K Buy
27,300
+19,300
+241% +$478K ﹤0.01% 6029
2017
Q1
$215K Buy
+8,000
New +$221K ﹤0.01% 7900
2015
Q3
Sell
-29,100
Closed -$416K 10553
2015
Q2
$416K Buy
+29,100
New +$493K ﹤0.01% 7973
2014
Q3
Sell
-32,600
Closed -$468K 10237
2014
Q2
$468K Buy
+32,600
New +$426K ﹤0.01% 7597

Other funds holding NXTM

Susquehanna International Group's NXTM Position: Q1 2019 in Review

Susquehanna International Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 22,417 shares — an estimated $642K sold.

Susquehanna International Group first reported a position in NXTM in Q4 2013 and held it in 16 quarters. The position peaked at $4.9M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Susquehanna International Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Susquehanna International Group sold 22,417 NxStage Medical Inc. shares in Q1 2019, an estimated $642K.
  • Susquehanna International Group first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 16 quarters.
  • Susquehanna International Group's NxStage Medical Inc. position peaked at $4.9M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.